Medindia

X

3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

Thursday, January 31, 2008 General News J E 4
Advertisement
SHENYANG, China, Jan. 30 3SBio Inc.(Nasdaq: SSRX), a leading China-based biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, announces today that David Chen, VP of Business Development, willpresent at the Merrill Lynch Global Pharmaceutical, Biotechnology and MedicalDevice Conference at The Grand Hyatt hotel in New York on Tuesday, February 5,2008 at 11:00 A.M. (Eastern).

The presentation will be audio webcast live and can be accessed on theEvents section of the investors page of the 3SBio website athttp://bbs.3sbio.com/en/News/ShowInfo_nnn6.aspx?ID=65 . A replay of thepresentation and accompanying slides will be available on the 3SBio websiteuntil February 19, 2008.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China. For more information, please visit 3SBio on theweb at http://www.3sbio.com .For more information, please contact: Investor Contact: Kevin Teo, CFO 3SBio Inc. Tel: +86-24-2581-1820 Investor Relations(HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Investor Relations(US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Media Contact: John Dooley Taylor Rafferty Tel: +1-212-889-4350

SOURCE 3SBio Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Tengion to Present at Merrill Lynch Global Pharmac...
S
Photos: Niavin Corporation Offers Pain Sufferers a...